Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance.
- NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_assertion description "[Because TF expression is associated with an enhanced risk of metastasis, we postulate that the progesterone-dependent up-regulation of TF provides a survival advantage to burgeoning breast cancer cells and may contribute to the increased risk of cancer associated with combined hormone replacement therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance.
- NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_assertion evidence source_evidence_literature NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance.
- NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_assertion SIO_000772 15562024 NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance.
- NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_assertion wasDerivedFrom befree-2016 NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance.
- NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_assertion wasGeneratedBy ECO_0000203 NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance.
- befree-2016 importedOn "2016-02-19" NP470093.RAVA2P7z9k3eIggsFX4QzXyWKGtu4H_8RtafUY9D65hYE130_provenance.